Topical Advisory Panel

Topical Advisory Panel Members (12)

Dr. Stefan Zielonka
Protein Engineering and Antibody Technologies, Merck KGaA, Darmstadt, Germany
Interests: antibody hit discovery; antibody engineering; protein engineering; bispecific antibodies; monoclonal antibodies; single domain antibodies; immune cell redirection; immunoligands; antagonistic antibodies; agonistic antibodies; immune checkpoint inhibitors; phage display; yeast surface display; mammalian display; B cell selection strategies
Special Issues, Collections and Topics in MDPI journals
Dr. Antu K. Dey
International AIDS Vaccine Initiative, New York, NY, USA
Interests: vaccines & bio-pharmaceutical product development; antibody development; product and process development; analytical assay development; method verification/qualification/validation; quality by design; RNA vaccine; cGMP manufacturing; contract (CMO/CRO) manufacturing; RNA aptamers; protein purification and analytical characterization; analysis of vaccine immune response; vaccine adjuvants and formulation; vaccine/drug delivery
Dr. Monica Berrondo
Macromoltek, Inc., 2500 W William Cannon Dr, Suite 204, Austin, TX 78745, USA
Interests: antibody discovery; antibody structure prediction and analysis; protein mutational analysis; antibody design; protein design; deep learning; machine learning; structural biology
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Bogdan Petrunov
National Centre of Infectious and Parasitic Diseases (NCIPD), Sofia, Bulgaria
Interests: immunoglobulin E; flow cytometry; immunology; immunity; immune response; T lymphocytes; allergology; clinical immunology; infectious immunology; immunomodulation and immunomodulators; allergens and allergen preparations; specific immunotherapy/hyposensitization
Dr. Alessandra Micaela Villa
Philochem AG, R&D unit of the Philogen Group, Otelfingen, Switzerland
Interests: monoclonal antibodies; antibody engineering; antibodies; phage display; recombinant protein expression; recombinant antibodies; tumor angiogenesis; immunohistochemistry; flow cytometry; immunofluorescence; cloning; cell culture; targeted therapeutics
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Marie-Alix Poul
Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), F-34298 Montpellier, France
Interests: antibody pharmacodynamics; antibody engineering; switchable antibodies; phage and yeast display; immunotherapy; tumor microenvironment; iron metabolism
Dr. Anne Zeck
NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany
Interests: recombinant antibodies; therapeutic antibodies; characterization of recombinant antibodies with mass spectrometry based methods; immunoanalytical detection of chromatographic separations; chromatography and mass spectrometry of peptides and proteins; developability of therapeutic antibodies; Immunoanalytical methods for the production and characterization of antibodies; therapeutic antibodies sequence variant analysis; therapeutic antibodies accelerated stress conditions; therapeutic antibodies epitope mapping by HDX, PTM characterization
Dr. Katja Klausz
Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany
Interests: antibody therapy; Fc fragment crystallizable (Fc); Fc engineering; complement-dependent cytotoxicity (CDC); antibody-dependent cell-mediated cytotoxicity (ADCC); Translational Research; oncology/cancer; immunotherapy
Dr. Nathan D. Trinklein
TeneoBio, Inc. 7999 Gateway Blvd, Newark, CA 94560, USA
Interests: antibody discovery; immune agonists; multi-specific antibodies; bispecific antibody; cancer; autoimmunity; infectious diseases
Dr. Michael R. Dyson
Ichnos Sciences Biotherapeutics SA: Lausanne, Vaud, Switzerland
Interests: antibody Engineering; therapeutic antibodies; antibody discoveryand development technologies; antibody phage display library; bi-specific antibody; molecular biology; library generation and screening; novel antibody therapeutics; antibody formats; antibody and scaffold phage display; cell line engineering; assay development and protein biochemistry; protein purification; affinity determination; in silico and wet lab developability screens; NGS analysis; database tracking and pre-clinical development
Dr. John P. Giddens
Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology and the University of Maryland, 9600 Gudelsky Drive, Rockville, MD 20850, USA
Interests: glycobiology; antibody engineering; fc receptor biology; antibody purification; mass spectrometry; glycoengineering; chemoenzymatic synthesis
Dr. Leonardo M. Cortez
Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, AB, Canada
Interests: neuroscience; biochemistry; medical science; alzheimer's disease; biophysics; medical neurosciences; protein folding; protein aggregation; amyloid; protein misfolding; prion diseases
Back to TopTop